Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
about
[Malignant melanoma : Current status].Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers.Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review.Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer.Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond
P2860
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
@en
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
@nl
type
label
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
@en
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
@nl
prefLabel
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
@en
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
@nl
P2093
P2860
P356
P1433
P1476
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment
@en
P2093
A Kopp-Schneider
J C Hassel
P2860
P304
P356
10.2217/IMT-2016-0083
P577
2016-09-01T00:00:00Z